Current Assets Endring Dato
Adcock Ingram Holdings ZAR 4.69B 76.51M 2023-12
Agios Pharmaceuticals USD 663.63M 170.21M 2024-03
Alnylam Pharmaceuticals USD 2.99B 5.91M 2024-03
Arrowhead Research USD 541.65M 303.75M 2024-03
Astellas Pharma JPY 1.05T 66.65B 2023-12
BioMarin Pharmaceutical USD 2.99B 28.92M 2024-03
Celltrion KRW 362.37B 4.65T 2024-03
Cspc Pharmaceutical CNY 26.74B 2.36B 2023-12
Ecofibre AUD 39.4M 17.77M 2023-12
Exelixis USD 1.29B 150.94M 2024-03
Halozyme Therapeutics USD 873.58M 127.16M 2024-03
Ionis Pharmaceuticals USD 2.42B 226.18M 2024-03
Kangmei Pharma CNY 6.86B 164.51M 2024-03
Knight Therapeutics CAD 388.44M 23.33M 2024-03
Laboratorios Farma EUR 485.42M 23.92M 2024-03
Malin Corporation EUR 35.8M 3M 2023-12
Medical Developments International AUD 31.03M 11.73M 2023-12
Moderna USD 9.6B 725M 2024-03
Neuren Pharmaceuticals AUD 247.16M 150.76M 2023-12
Neurocrine Biosciences USD 1.8B 149.1M 2024-03
Novartis USD 26.45B 4.03B 2024-03
OPKO Health USD 391.3M 81.83M 2024-03
Organigram Holdings CAD 194.26M 33.97M 2024-03
Pfizer USD 42.42B 31.6B 2024-03
Pharma Mar EUR 241.36M 11.24M 2024-03
Probiotec AUD 72.62M 3.05M 2023-12
PTC Therapeutics USD 1.17B 49.89M 2024-03
Qiagen NV USD 1.89B 256.8M 2024-03
Regeneron Pharmaceuticals USD 18.87B 5.62B 2024-03
Roche Holding CHF 33.45B 2.47B 2023-12
Sarepta Therapeutics USD 2.46B 14.02M 2024-03
Sartorius EUR 2.78B 822.2M 2024-03
Sino Biopharmaceutical CNY 23.81B 3.17B 2023-12
Tilray USD 631.21M 10.82M 2024-02
Ultragenyx Pharmaceutical USD 595.97M 3.22M 2024-03
Vertex Pharmaceuticals USD 13.29B 1.41B 2024-03
Zz Pientze Pharmaceu 14.13B 141.28M 2023-09



Ionis Pharmaceuticals Omløpsmidler - Gjeldende verdier, historiske data, prognoser, statistikk, diagrammer og økonomiske kalender - Jun 2024.